Revolution Medicines Inc (NAS:RVMDW)
$ 0.76 0.11 (16.92%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 6.47 GF Score: 41/100

Q3 2023 Revolution Medicines Inc Earnings Call Transcript

Nov 06, 2023 / 09:30PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Revolution Medicines Q3 2023 Earnings Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker, Erin Graves, Senior Director of Corporate Communications and Investor Relations. Please go ahead.

Erin Graves
Revolution Medicines, Inc. - Senior Director of Corporate Communications & IR

Thank you, and welcome, everyone, to the third quarter 2023 earnings call. Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicine's Chairman and Chief Executive Officer; and Jack Anders, our Chief Financial Officer. Dr. Steve Kelsey, our President of R&D, will join us for the Q&A portion of today's call.

As we begin, I would like to note that our presentation will include statements regarding the current beliefs of Revolution Medicines with respect to our business and the proposed acquisition of EQRx, including statements regarding our development plans and time lines for our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot